Pacific Biosciences of California Inc. buy Zacks Research
Start price
21.02.26
/
50%
€1.34
Target price
21.02.27
-
Performance (%)
-12.01%
Price
07.04.26
€1.25
Summary
This prediction is currently active. The price of Pacific Biosciences of California Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.01%. This prediction currently runs until 21.02.27. The prediction end date can be changed by Zacks_Research at any time. Zacks_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | 9.471% | 9.471% |
| iShares Core DAX® | 0,23 % | -2,41 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % |
| iShares S&P 500 | 1,07 % | -1,58 % |
Comments by Zacks_Research for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PACB provided by MarketBeat